MARKET

INFI

INFI

Infinity Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.9750
+0.0850
+9.55%
Closed 16:00 04/08 EDT
OPEN
0.9097
PREV CLOSE
0.8900
HIGH
0.9800
LOW
0.9001
VOLUME
85.16K
TURNOVER
--
52 WEEK HIGH
1.860
52 WEEK LOW
0.6000
MARKET CAP
56.00M
P/E (TTM)
-1.1807
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average INFI stock price target is 2.875 with a high estimate of 3.500 and a low estimate of 1.500.

EPS

INFI News

More
  • Bristol-Myers Squibb to provide medicines to the unemployed and uninsured
  • seekingalpha · 1d ago
  • Infinity Pharmaceuticals Provides Update in Response to COVID-19 Pandemic
  • Business Wire · 1d ago
  • Infinity (INFI) Down 28.2% Since Last Earnings Report: Can It Rebound?
  • Zacks · 6d ago
  • Infinity's IPI-549 Gets Fast Track Tag for Urothelial Cancer
  • Zacks · 03/26 23:07

Industry

Biotechnology & Medical Research
+3.08%
Pharmaceuticals & Medical Research
+2.83%

Hot Stocks

Symbol
Price
%Change

About INFI

Infinity Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in the discovery, development and delivery of medicines to treat diseases. The Company develops small molecule drugs that target disease pathways for potential applications in oncology. Its product candidate is duvelisib, also known as IPI-145, is an oral, dual-inhibitor of the delta and gamma isoforms of phosphoinositide-3-kinase (PI3K), for the treatment of hematologic malignancies, or blood cancers. The Company is also developing IPI-549, which is an orally administered, clinical-stage, immuno-oncology product candidate that selectively inhibits the gamma isoform of PI3K. In addition to duvelisib, the Company focuses to generate new product candidates for potential investigation in oncology. The Company also focuses on developing DYNAMO, CONTEMPO, BRAVURA, FRESCO, DYNAMO+R, DUO, SYNCHRONY and Duvelisib + Venetoclax.
More

Webull offers kinds of Infinity Pharmaceuticals Inc. stock information, including NASDAQ:INFI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INFI stock news, and many more online research tools to help you make informed decisions.